SYNTAX Score 2020 Risk Estimates Between PCI and CABG in Coronary Artery Disease : A Descriptive Study

  • Alysa Masytha Masyhudi Department of Cardiology and Vascular Medicine dr. Doris Sylvanus Regional General Hospital, Palangka Raya, Indonesia https://orcid.org/0009-0003-6798-1384
  • Sanggap Indra Sitompul Department of Cardiology and Vascular Medicine dr. Doris Sylvanus Regional General Hospital/University of Palangka Raya, Palangka Raya, Indonesia
  • Karina Yesika Manalu Department of Cardiology and Vascular Medicine dr. Doris Sylvanus Regional General Hospital, Palangka Raya, Indonesia
  • Refiansyah Tri Anggoro University of Palangka Raya, Palangka Raya, Indonesia.
  • Yusuf Galenta Department of Cardiology and Vascular Medicine dr. Doris Sylvanus Regional General Hospital/University of Palangka Raya, Palangka Raya, Indonesia
Keywords: SYNTAX Score 2020, Coronary Artery Disease, Coronary Revascularization, Interventional Cardiology

Abstract

Background:

The SYNTAX Score 2020 is a validated tool that combines anatomical and clinical parameters to estimate long-term outcomes in CAD and guide revascularization decisions between PCI and CABG. Although its components are well defined, further studies are needed to clarify how clinical variables influence risk predictions in diverse populations, including Indonesia.

 

Methods:

This cross-sectional study enrolled 115 patients with angiographically confirmed CAD at dr. Doris Sylvanus Regional General Hospital, Palangka Raya, Indonesia, between January and June 2025. The SYNTAX Score 2020 and anatomical SYNTAX Score I were calculated using the official application. Statistical analyses included bivariate non-parametric tests, Spearman correlations, and multivariate linear regression to identify independent clinical determinants of the SYNTAX Score 2020–predicted 10-year mortality and 5-year MACE following PCI and CABG.

 

Results:

PVD and DM were strongly associated with a higher SYNTAX Score 2020–predicted 5-year MACE and 10-year mortality after both PCI and CABG, with a stepwise increase in risk from no DM to insulin-treated DM. LMCAD was associated with a higher CABG-predicted risk than 3VD, whereas smoking was not associated with predicted outcomes. Age and SYNTAX Score I were positively correlated with all risk estimates, whereas CrCl and LVEF were inversely correlated. In the multivariate models, age, PVD, DM, and lower LVEF remained independent predictors for both strategies; SYNTAX Score I remained significant only for PCI, and CrCl was no longer independently associated with risk.

 

Conclusion:

Age was the main independent predictor of a higher SYNTAX Score 2020 that predicted long-term risk, followed by PVD and diabetes (highest in insulin-treated DM). Higher LVEF was protective, and left main disease carried a higher predicted risk than three-vessel disease.

Downloads

Download data is not yet available.

References

1. Valencia J, Malaluan N, Cheng P, Alvarez M, Sy R, Punzalan F. Epidemiology of cardiovascular diseases in Southeast Asia: a systematic review. Philipp J Cardiol. 2021;49(2):69–75. doi:10.69944/pjc.4bb9b9314a.
2. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization. J Am Coll Cardiol. 2022;79(2):e21–e129. doi:10.1016/j.jacc.2021.09.005.
3. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165. doi:10.1093/eurheartj/ehy394.
4. Takahashi K, Serruys PW, Fuster V, Farkouh ME, Spertus JA, Cohen DJ, et al. Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease. Lancet. 2020;396(10260):1399–1412. doi:10.1016/S0140-6736(20)32114-0.
5. Hara H, Shiomi H, van Klaveren D, Kent DM, Steyerberg EW, Garg S, et al. External validation of the SYNTAX Score II 2020. J Am Coll Cardiol. 2021;78(12):1227–1238. doi:10.1016/j.jacc.2021.07.027.
6. American Diabetes Association Professional Practice Committee. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S19–S40. doi:10.2337/dc23-S002.
7. Mazzolai L, Teixidó-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al.; ESC Scientific Document Group. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538–3700. doi:10.1093/eurheartj/ehae179.
8. Sahajanand Medical Technologies Pvt Ltd. SYNTAX Score 2020 [mobile application]. Version 1.3.3. Pune (IN): Sahajanand Medical Technologies Pvt Ltd; 2020. Accessed 7 Nov 2025.
9. Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart. 2018;104:284–292.
10. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–477. doi:10.1093/eurheartj/ehz425.
11. Li X, Xiao F, Zhang S. Coronary revascularisation in patients with chronic kidney disease and end-stage renal disease: a meta-analysis. Int J Clin Pract. 2021;75:e14506.
12. Grazioli V, et al. Myocardial revascularization in patients with chronic kidney disease: CABG versus PCI. Interact Cardiovasc Thorac Surg. 2025;40(3):ivaf021.
13. Tam DY, Dharma C, Rocha RV, Austin PC, Wijeysundera HC, Farkouh ME, et al. Long-term survival after surgical or percutaneous revascularization in patients with diabetes and multivessel coronary disease. J Am Coll Cardiol. 2020;76:1153–1164.
14. Tam DY, Dharma C, Rocha RV, et al. Revascularization strategies for the treatment of multivessel coronary artery disease in patients with diabetes mellitus. Circ Cardiovasc Interv. 2020;13(9):e009082.
15. Aboul-Hassan SS, et al. Impact of incomplete revascularization on long-term survival based on revascularization strategy. Ann Thorac Surg. 2024.
16. Kim T, Kang DY, Kim S, et al. Impact of complete or incomplete revascularization for left main coronary disease: the extended PRECOMBAT study. JACC Asia. 2023;3(1):65–74. doi:10.1016/j.jacasi.2022.10.007.
17. Higashi Y, et al. Smoking cessation and vascular endothelial function. Hypertens Res. 2023;46(12):2670–2678. doi:10.1038/s41440-023-01455-z.
18. Jia X, et al. Tobacco use and endothelial function: a meta-analysis. BMC Cardiovasc Disord. 2024;24:391. doi:10.1186/s12872-024-03915-x.
19. Polman R, Hurst JR, Uysal OF, Mandal S, Linz D, Simons S. Cardiovascular disease and risk in COPD: a state-of-the-art review. Expert Rev Respir Med. 2024;18(4):317–329. doi:10.1080/17476348.2024.2333786.
20. Heffernan M, Rutherford S. The intersection of COPD and cardiovascular disease. Cardiopulm Care Rev. 2025; article in press. doi:10.1016/j.cjco.2025.01.001.
Published
2026-08-03
Views & Downloads
Abstract views: 61   
PDF downloads: 14   
How to Cite
Masyhudi, A., Sitompul, S., Manalu, K., Anggoro, R., & Galenta, Y. (2026). SYNTAX Score 2020 Risk Estimates Between PCI and CABG in Coronary Artery Disease : A Descriptive Study. Indonesian Journal of Cardiology. https://doi.org/10.30701/ijc.2050
Section
Clinical Research